Q9BZ11 (ADA33_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 126.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Disintegrin and metalloproteinase domain-containing protein 33 Short name=ADAM 33 EC=3.4.24.- | ||||||
| Gene names |
| ||||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||||
| Taxonomic identifier | 9606 [NCBI] | ||||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 813 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Cofactor | Binds 1 zinc ion per subunit By similarity. |
| Subcellular location | |
| Tissue specificity | Expressed in all tissues, except liver, with high expression in placenta, lung, spleen and veins. Ref.1 |
| Domain | The conserved cysteine present in the cysteine-switch motif binds the catalytic zinc ion, thus inhibiting the enzyme. The dissociation of the cysteine from the zinc ion upon the activation-peptide release activates the enzyme. |
| Post-translational modification | The precursor is cleaved by a furin endopeptidase By similarity. |
| Involvement in disease | Asthma (ASTHMA) [MIM:600807]: The most common chronic disease affecting children and young adults. It is a complex genetic disorder with a heterogeneous phenotype, largely attributed to the interactions among many genes and between these genes and the environment. It is characterized by recurrent attacks of paroxysmal dyspnea, with weezing due to spasmodic contraction of the bronchi. |
| Sequence similarities | Contains 1 disintegrin domain. Contains 1 EGF-like domain. Contains 1 peptidase M12B domain. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Membrane |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Disease | Asthma |
| Domain | EGF-like domain Signal Transmembrane Transmembrane helix |
| Ligand | Metal-binding Zinc |
| Molecular function | Hydrolase Metalloprotease Protease |
| PTM | Cleavage on pair of basic residues Disulfide bond Glycoprotein Zymogen |
| Technical term | 3D-structure Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | proteolysis Non-traceable author statement Ref.1. Source: UniProtKB |
| Cellular_component | integral to membrane Non-traceable author statement Ref.1. Source: UniProtKB |
| Molecular_function | metalloendopeptidase activity Non-traceable author statement Ref.1. Source: UniProtKB zinc ion bindingNon-traceable author statement Ref.1. Source: UniProtKB |
| Complete GO annotation... | |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q9BZ11-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q9BZ11-2) The sequence of this isoform differs from the canonical sequence as follows: 636-661: Missing. | ||||||
| Isoform 3 (identifier: Q9BZ11-3) The sequence of this isoform differs from the canonical sequence as follows: 1-478: Missing. 636-661: Missing. | ||||||
| Note: No experimental confirmation available. By similarity with mouse isoform. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 29 | 29 | Potential | |||||||||||||||||||||||||||||||||||||
| Propeptide | 30 – 203 | 174 | By similarity | PRO_0000029142 | ||||||||||||||||||||||||||||||||||||
| Chain | 204 – 813 | 610 | Disintegrin and metalloproteinase domain-containing protein 33 | PRO_0000029143 | ||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||
| Topological domain | 30 – 701 | 672 | Extracellular Potential | |||||||||||||||||||||||||||||||||||||
| Transmembrane | 702 – 722 | 21 | Helical; Potential | |||||||||||||||||||||||||||||||||||||
| Topological domain | 723 – 813 | 91 | Cytoplasmic Potential | |||||||||||||||||||||||||||||||||||||
| Domain | 210 – 409 | 200 | Peptidase M12B | |||||||||||||||||||||||||||||||||||||
| Domain | 417 – 503 | 87 | Disintegrin | |||||||||||||||||||||||||||||||||||||
| Domain | 649 – 681 | 33 | EGF-like | |||||||||||||||||||||||||||||||||||||
| Motif | 131 – 138 | 8 | Cysteine switch By similarity | |||||||||||||||||||||||||||||||||||||
| Compositional bias | 503 – 648 | 146 | Cys-rich | |||||||||||||||||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||||||||||||||||
| Active site | 346 | 1 | By similarity | |||||||||||||||||||||||||||||||||||||
| Metal binding | 133 | 1 | Zinc; in inhibited form By similarity | |||||||||||||||||||||||||||||||||||||
| Metal binding | 345 | 1 | Zinc; catalytic | |||||||||||||||||||||||||||||||||||||
| Metal binding | 349 | 1 | Zinc; catalytic | |||||||||||||||||||||||||||||||||||||
| Metal binding | 355 | 1 | Zinc; catalytic | |||||||||||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||||||||||
| Glycosylation | 109 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||||||||||||||
| Glycosylation | 145 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||||||||||||||
| Glycosylation | 231 | 1 | N-linked (GlcNAc...) | |||||||||||||||||||||||||||||||||||||
| Glycosylation | 276 | 1 | N-linked (GlcNAc...) | |||||||||||||||||||||||||||||||||||||
| Glycosylation | 448 | 1 | N-linked (GlcNAc...) Potential | |||||||||||||||||||||||||||||||||||||
| Disulfide bond | 320 ↔ 404 | |||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 360 ↔ 388 | |||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 361 ↔ 371 | |||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 475 ↔ 495 | By similarity | ||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 653 ↔ 663 | By similarity | ||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 657 ↔ 669 | By similarity | ||||||||||||||||||||||||||||||||||||||
| Disulfide bond | 671 ↔ 680 | By similarity | ||||||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 1 – 478 | 478 | Missing in isoform 3. | VSP_015421 | ||||||||||||||||||||||||||||||||||||
| Alternative sequence | 636 – 661 | 26 | Missing in isoform 2 and isoform 3. | VSP_005495 | ||||||||||||||||||||||||||||||||||||
| Natural variant | 109 | 1 | N → S. Ref.4 Corresponds to variant rs41467948 [ dbSNP | Ensembl ]. | VAR_030512 | ||||||||||||||||||||||||||||||||||||
| Natural variant | 178 | 1 | T → A. Ref.4 Corresponds to variant rs3918392 [ dbSNP | Ensembl ]. | VAR_029143 | ||||||||||||||||||||||||||||||||||||
| Natural variant | 272 | 1 | T → M. Ref.4 Corresponds to variant rs41534847 [ dbSNP | Ensembl ]. | VAR_030513 | ||||||||||||||||||||||||||||||||||||
| Natural variant | 305 | 1 | A → V in a cutaneous metastatic melanoma sample; somatic mutation. Ref.9 | VAR_066337 | ||||||||||||||||||||||||||||||||||||
| Natural variant | 316 | 1 | V → I. Ref.4 Corresponds to variant rs41459049 [ dbSNP | Ensembl ]. | VAR_030514 | ||||||||||||||||||||||||||||||||||||
| Natural variant | 336 | 1 | P → S. Ref.4 Corresponds to variant rs41483049 [ dbSNP | Ensembl ]. | VAR_030515 | ||||||||||||||||||||||||||||||||||||
| Natural variant | 365 | 1 | A → S. Ref.4 Corresponds to variant rs41419248 [ dbSNP | Ensembl ]. | VAR_030516 | ||||||||||||||||||||||||||||||||||||
| Natural variant | 441 | 1 | D → E. Ref.4 Corresponds to variant rs41382144 [ dbSNP | Ensembl ]. | VAR_030517 | ||||||||||||||||||||||||||||||||||||
| Natural variant | 515 | 1 | W → R. Ref.4 Corresponds to variant rs615436 [ dbSNP | Ensembl ]. | VAR_030518 | ||||||||||||||||||||||||||||||||||||
| Natural variant | 612 | 1 | L → H. Ref.4 Corresponds to variant rs41453444 [ dbSNP | Ensembl ]. | VAR_030519 | ||||||||||||||||||||||||||||||||||||
| Natural variant | 710 | 1 | V → I. Ref.4 Corresponds to variant rs3918396 [ dbSNP | Ensembl ]. | VAR_030520 | ||||||||||||||||||||||||||||||||||||
| Natural variant | 739 | 1 | C → G. Ref.4 Corresponds to variant rs41434648 [ dbSNP | Ensembl ]. | VAR_030521 | ||||||||||||||||||||||||||||||||||||
| Natural variant | 742 | 1 | D → Y. Ref.4 Corresponds to variant rs41462450 [ dbSNP | Ensembl ]. | VAR_030522 | ||||||||||||||||||||||||||||||||||||
| Natural variant | 764 | 1 | M → T. Ref.4 Corresponds to variant rs2280091 [ dbSNP | Ensembl ]. | VAR_021847 | ||||||||||||||||||||||||||||||||||||
| Natural variant | 774 | 1 | P → S. Ref.4 Corresponds to variant rs2280090 [ dbSNP | Ensembl ]. | VAR_029144 | ||||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||||
| Sequence conflict | 802 | 1 | Missing in AAM80482. Ref.2 | |||||||||||||||||||||||||||||||||||||
| Sequence conflict | 802 | 1 | Missing in AAM80483. Ref.2 | |||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||
| Beta strand | 210 – 218 | 9 | ||||||||||||||||||||||||||||||||||||||
| Helix | 220 – 225 | 6 | ||||||||||||||||||||||||||||||||||||||
| Turn | 226 – 228 | 3 | ||||||||||||||||||||||||||||||||||||||
| Helix | 230 – 248 | 19 | ||||||||||||||||||||||||||||||||||||||
| Helix | 249 – 251 | 3 | ||||||||||||||||||||||||||||||||||||||
| Beta strand | 253 – 262 | 10 | ||||||||||||||||||||||||||||||||||||||
| Beta strand | 264 – 266 | 3 | ||||||||||||||||||||||||||||||||||||||
| Helix | 275 – 292 | 18 | ||||||||||||||||||||||||||||||||||||||
| Beta strand | 296 – 303 | 8 | ||||||||||||||||||||||||||||||||||||||
| Helix | 307 – 309 | 3 | ||||||||||||||||||||||||||||||||||||||
| Turn | 322 – 324 | 3 | ||||||||||||||||||||||||||||||||||||||
| Beta strand | 326 – 330 | 5 | ||||||||||||||||||||||||||||||||||||||
| Beta strand | 333 – 335 | 3 | ||||||||||||||||||||||||||||||||||||||
| Helix | 336 – 350 | 15 | ||||||||||||||||||||||||||||||||||||||
| Helix | 366 – 368 | 3 | ||||||||||||||||||||||||||||||||||||||
| Helix | 387 – 398 | 12 | ||||||||||||||||||||||||||||||||||||||
| Turn | 399 – 402 | 4 | ||||||||||||||||||||||||||||||||||||||
| Helix | 403 – 406 | 4 | ||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Identification and characterization of novel mouse and human ADAM33s with potential metalloprotease activity." Yoshinaka T., Nishii K., Yamada K., Sawada H., Nishiwaki E., Smith K., Yoshino K., Ishiguro H., Higashiyama S. Gene 282:227-236(2002) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), TISSUE SPECIFICITY. Tissue: Testis. |
| [2] | "Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness." Van Eerdewegh P., Little R.D., Dupuis J., Del Mastro R.G., Falls K., Simon J., Torrey D., Pandit S., McKenny J., Braunschweiger K., Walsh A., Liu Z., Hayward B., Folz C., Manning S.P., Bawa A., Saracino L., Thackston M. Keith T.P.Nature 418:426-430(2002) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), INVOLVEMENT IN ASTHMA. Tissue: Uterus. |
| [3] | "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment." Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J., Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P., Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E. Gray A.M.Genome Res. 13:2265-2270(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). |
| [4] | NIEHS SNPs program Submitted (SEP-2006) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS SER-109; ALA-178; MET-272; ILE-316; SER-336; SER-365; GLU-441; ARG-515; HIS-612; ILE-710; GLY-739; TYR-742; THR-764 AND SER-774. |
| [5] | "The DNA sequence and comparative analysis of human chromosome 20." Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R., Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L., Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P., Bird C.P., Blakey S.E. Rogers J.Nature 414:865-871(2001) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "ADAM33 haplotypes are associated with asthma in a large Australian population." Kedda M.A., Duffy D.L., Bradley B., O'Hehir R.E., Thompson P.J. Eur. J. Hum. Genet. 14:1027-1036(2006) [PubMed] [Europe PMC] [Abstract] Cited for: INVOLVEMENT IN SUSCEPTIBILITY TO ASTHMA. |
| [7] | "Positionally cloned asthma susceptibility gene polymorphisms and disease risk in the British 1958 Birth Cohort." Blakey J.D., Sayers I., Ring S.M., Strachan D.P., Hall I.P. Thorax 64:381-387(2009) [PubMed] [Europe PMC] [Abstract] Cited for: INVOLVEMENT IN SUSCEPTIBILITY TO ASTHMA. |
| [8] | "Crystal structure of the catalytic domain of human ADAM33." Orth P., Reichert P., Wang W., Prosise W.W., Yarosh-Tomaine T., Hammond G., Ingram R.N., Xiao L., Mirza U.A., Zou J., Strickland C., Taremi S.S., Le H.V., Madison V. J. Mol. Biol. 335:129-137(2004) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.58 ANGSTROMS) OF 204-410 IN COMPLEX WITH METALLOPROTEASE INHIBITOR MARIMASTAT, X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 204-410. |
| [9] | "Analysis of the disintegrin-metalloproteinases family reveals ADAM29 and ADAM7 are often mutated in melanoma." Wei X., Moncada-Pazos A., Cal S., Soria-Valles C., Gartner J., Rudloff U., Lin J.C., Rosenberg S.A., Lopez-Otin C., Samuels Y. Hum. Mutat. 32:E2148-E2175(2011) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT VAL-305. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AB055891 mRNA. Translation: BAB83092.1. AF466287 mRNA. Translation: AAM80482.1. AF466288 Genomic DNA. Translation: AAM80483.1. AY358314 mRNA. Translation: AAQ88680.1. DQ995342 Genomic DNA. Translation: ABI97387.1. AL109804, AL356755 Genomic DNA. Translation: CAI18840.1. | ||||||||||||||||||
| IPI | IPI00079482. IPI00218715. IPI00642419. | ||||||||||||||||||
| RefSeq | NP_079496.1. NM_025220.2. NP_694882.1. NM_153202.1. | ||||||||||||||||||
| UniGene | Hs.173716. | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||
| ProteinModelPortal | Q9BZ11. | ||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| IntAct | Q9BZ11. 2 interactions. | ||||||||||||||||||
| MINT | MINT-2876745. | ||||||||||||||||||
| STRING | 9606.ENSP00000348912. | ||||||||||||||||||
Protein family/group databases | |||||||||||||||||||
| MEROPS | M12.244. | ||||||||||||||||||
PTM databases | |||||||||||||||||||
| PhosphoSite | Q9BZ11. | ||||||||||||||||||
Polymorphism databases | |||||||||||||||||||
| DMDM | 20137458. | ||||||||||||||||||
Proteomic databases | |||||||||||||||||||
| PaxDb | Q9BZ11. | ||||||||||||||||||
| PRIDE | Q9BZ11. | ||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||
Genome annotation databases | |||||||||||||||||||
| Ensembl | ENST00000350009; ENSP00000322550; ENSG00000149451. ENST00000356518; ENSP00000348912; ENSG00000149451. | ||||||||||||||||||
| GeneID | 80332. | ||||||||||||||||||
| KEGG | hsa:80332. | ||||||||||||||||||
| UCSC | uc002wis.3. human. uc002wit.3. human. uc002wiu.3. human. | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| CTD | 80332. | ||||||||||||||||||
| GeneCards | GC20M003596. | ||||||||||||||||||
| HGNC | HGNC:15478. ADAM33. | ||||||||||||||||||
| MIM | 600807. phenotype. 607114. gene. | ||||||||||||||||||
| neXtProt | NX_Q9BZ11. | ||||||||||||||||||
| PharmGKB | PA24526. | ||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| eggNOG | NOG294463. | ||||||||||||||||||
| HOGENOM | HOG000230883. | ||||||||||||||||||
| HOVERGEN | HBG006978. | ||||||||||||||||||
| InParanoid | Q9BZ11. | ||||||||||||||||||
| KO | K08616. | ||||||||||||||||||
| OMA | DGSPCAR. | ||||||||||||||||||
| OrthoDB | EOG4CJVGF. | ||||||||||||||||||
| PhylomeDB | Q9BZ11. | ||||||||||||||||||
Gene expression databases | |||||||||||||||||||
| ArrayExpress | Q9BZ11. | ||||||||||||||||||
| Bgee | Q9BZ11. | ||||||||||||||||||
| CleanEx | HS_ADAM33. | ||||||||||||||||||
| Genevestigator | Q9BZ11. | ||||||||||||||||||
| GermOnline | ENSG00000149451. Homo sapiens. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| Gene3D | 3.40.390.10. 1 hit. 4.10.70.10. 1 hit. | ||||||||||||||||||
| InterPro | IPR006586. ADAM_Cys-rich. IPR001762. Blood-coag_inhib_Disintegrin. IPR018358. Disintegrin_CS. IPR000742. EG-like_dom. IPR013032. EGF-like_CS. IPR024079. MetalloPept_cat_dom. IPR001590. Peptidase_M12B. IPR002870. Peptidase_M12B_N. [Graphical view] | ||||||||||||||||||
| Pfam | PF08516. ADAM_CR. 1 hit. PF00200. Disintegrin. 1 hit. PF01562. Pep_M12B_propep. 1 hit. PF01421. Reprolysin. 1 hit. [Graphical view] | ||||||||||||||||||
| PRINTS | PR00289. DISINTEGRIN. | ||||||||||||||||||
| SMART | SM00608. ACR. 1 hit. SM00050. DISIN. 1 hit. SM00181. EGF. 1 hit. [Graphical view] | ||||||||||||||||||
| SUPFAM | SSF57552. Disintegrin. 1 hit. | ||||||||||||||||||
| PROSITE | PS50215. ADAM_MEPRO. 1 hit. PS00546. CYSTEINE_SWITCH. False negative. PS00427. DISINTEGRIN_1. 1 hit. PS50214. DISINTEGRIN_2. 1 hit. PS00022. EGF_1. False negative. PS01186. EGF_2. 1 hit. PS50026. EGF_3. 1 hit. PS00142. ZINC_PROTEASE. 1 hit. [Graphical view] | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Other | |||||||||||||||||||
| BindingDB | Q9BZ11. | ||||||||||||||||||
| ChEMBL | CHEMBL6121. | ||||||||||||||||||
| EvolutionaryTrace | Q9BZ11. | ||||||||||||||||||
| GenomeRNAi | 80332. | ||||||||||||||||||
| NextBio | 70880. | ||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||
Entry information
| Entry name | ADA33_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9BZ11 Secondary accession number(s): A0A1K6 Q8N0W6 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Peptidase families Classification of peptidase families and list of entries |
| Human chromosome 20 Human chromosome 20: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
